Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) today announced that the final results from its COSIRA study assessing the efficacy and safety of the Neovasc Reducer™ for treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback